Editorial Comment on: Risk Factors for Postoperative Fever and Systemic Inflammatory Response Syndrome After Ureteroscopy for Stone Disease by Southern et al. (From: Southern JB,Higgins AM,Young AJ,et al. J Endourol 2019;33:516–522;DOI: 10.1089/end.2018.0789)
Restricted accessOtherFirst published online July, 2019
Editorial Comment on: Risk Factors for Postoperative Fever and Systemic Inflammatory Response Syndrome After Ureteroscopy for Stone Disease by Southern et al. (From: Southern JB,Higgins AM,Young AJ,et al. J Endourol 2019;33:516–522;DOI: 10.1089/end.2018.0789)
OrdonM, UrbachD, MamdaniM, SaskinR, D'A HoneyRJ, PaceKT. The surgical management of kidney stone disease: A population based time series analysis. J Urol, 2014; 192:1450–1456.
2.
MartovA, GravasS, EtemadianM, et al.Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: A matched case–control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol, 2015; 29:171–180.
3.
ChewBH, FlanniganR, KurtzM, GershmanB. A single dose of intraoperative antibiotics is sufficient to prevent urinary tract infection during ureteroscopy. J Endourol, 2016; 30:63–68.
4.
SouthernJB, HigginsAM, YoungAJ, KostAK, SchreiterBR, CliftonM, FulmerBR, GargT. Risk factors for postoperative fever and systemic inflammatory response syndrome after ureteroscopy for stone disease. J. Endourol, 2019; 33:516–522.
5.
FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 2018. Available at https://www.fda.gov/Drugs/DrugSafety/ucm628753.htm (Accessed April6, 2009).
